Development of simultaneous resistance to fluconazole in Candida albicans and Candida dubliniensis in a patient with AIDS

被引:52
作者
Ruhnke, M
Schmidt-Westhausen, A
Morschhäuser, J
机构
[1] Humboldt Univ, Innere Med Abt, D-13353 Berlin, Germany
[2] Univ Klinikum Charite, Zentrum Zahnmed, D-13353 Berlin, Germany
[3] Univ Wurzburg, Zentrum Infekt Forsch, D-97070 Wurzburg, Germany
关键词
D O I
10.1093/jac/46.2.291
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
In this report, we describe a patient with recurrent episodes of oral candidosis who finally suffered from fluconazole-refractory oral and oesophageal candidosis. The patient was monitored for 4 years until his death from AIDS. During the observation period, persistent colonization with both Candida albicans and Candida dubliniensis was observed. From the appearance of the first episode of oral candidosis, the patient was treated with fluconazole for 18 months. The infection became unresponsive to fluconazole 400 mg/day. In vitro susceptibility testing revealed the development of resistance to fluconazole in C. albicans and C, dubliniensis. Molecular typing confirmed the persistence of the same C. albicans and C. dubliniensis strains which developed resistance after up to 3 years of asymptomatic colonization. This observation demonstrates that Candida spp. other than C. albicans may develop resistance to fluconazole in a patient who is repeatedly exposed to the drug.
引用
收藏
页码:291 / 295
页数:5
相关论文
共 13 条
[1]   Reversible fluconazole resistance in Candida albicans: A potential in vitro model [J].
Calvet, HM ;
Yeaman, MR ;
Filler, SG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (03) :535-539
[2]   Candidiasis: The emergence of a novel species, Candida dubliniensis [J].
Coleman, DC ;
Sullivan, DJ ;
Bennett, DE ;
Moran, GP ;
Barry, HJ ;
Shanley, DB .
AIDS, 1997, 11 (05) :557-567
[3]   Development and characterization of complex DNA fingerprinting probes for the infectious yeast Candida dubliniensis [J].
Joly, S ;
Pujol, C ;
Rysz, M ;
Vargas, K ;
Soll, DR .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (04) :1035-1044
[4]   MOLECULAR EPIDEMIOLOGY OF CANDIDA ISOLATES FROM AIDS PATIENTS SHOWING DIFFERENT FLUCONAZOLE RESISTANCE PROFILES [J].
LISCHEWSKI, A ;
RUHNKE, M ;
TENNAGEN, I ;
SCHONIAN, G ;
MORSCHHAUSER, J ;
HACKER, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (03) :769-771
[5]   Infection due to fluconazole-resistant Candida in patients with AIDS: Prevalence and microbiology [J].
Maenza, JR ;
Merz, WG ;
Romagnoli, MJ ;
Keruly, JC ;
Moore, RD ;
Gallant, JE .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (01) :28-34
[6]   Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro [J].
Moran, GP ;
Sullivan, DJ ;
Henman, MC ;
McCreary, CE ;
Harrington, BJ ;
Shanley, DB ;
Coleman, DC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (03) :617-623
[7]   Identification of CARE-2-negative Candida albicans isolates as Candida dubliniensis [J].
Morschhäuser, J ;
Ruhnke, M ;
Michel, S ;
Hacker, J .
MYCOSES, 1999, 42 (1-2) :29-32
[8]   Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans [J].
Pinjon, E ;
Sullivan, D ;
Salkin, I ;
Shanley, D ;
Coleman, D .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (07) :2093-2095
[9]   EMERGENCE OF FLUCONAZOLE-RESISTANT STRAINS OF CANDIDA-ALBICANS IN PATIENTS WITH RECURRENT OROPHARYNGEAL CANDIDOSIS AND HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
RUHNKE, M ;
EIGLER, A ;
TENNAGEN, I ;
GEISELER, B ;
ENGELMANN, E ;
TRAUTMANN, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (09) :2092-2098
[10]   Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients [J].
Schoofs, A ;
Odds, FC ;
Colebunders, R ;
Ieven, M ;
Goossens, H .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1997, 16 (04) :296-300